Live vaccinations and immunocompromised patients

For many years, immunosuppression to treat autoimmune inflammatory rheumatic diseases has comprised corticosteroids and conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs) such as methotrexate and sulfasalazine.